Progression-Free Survival Should Not Be Used as a Primary End Point for Registration of Anticancer Drugs.
作者信息
Booth Christopher M, Eisenhauer Elizabeth A, Gyawali Bishal, Tannock Ian F
机构信息
Division of Cancer Care and Epidemiology, Queen's University Cancer Research Institute, Kingston, Canada.
Department of Oncology, Queen's University, Kingston, Canada.
出版信息
J Clin Oncol. 2023 Nov 10;41(32):4968-4972. doi: 10.1200/JCO.23.01423. Epub 2023 Sep 21.
PMID:37733981
Abstract
摘要
Zotero 插件